Both in Pharmaceuticals
Citius Pharmaceuticals vs Marker Therapeutics
Over the past year CTXR returned −66.7% and MRKR returned −0.8%; their daily moves had a correlation of 0.14.
CTXR −66.7% MRKR −0.8%Growth of $1, one year, split-adjusted
| Metric | CTXR | MRKR |
|---|---|---|
| Price | $0.5231 | $0.9800 |
| Market cap | $14.4M | $16.3M |
| Today | −7.10% | −2.97% |
| 1 month | −3.2% | −6.7% |
| 6 months | −25.3% | −32.9% |
| Year to date | −32.7% | −34.2% |
| 1 year | −65.4% | +1.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | 67.1% | — |
| Net margin | −593.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.0× | 7.0× |
| Net cash | $10.6M | $11.3M |
| Dividend yield | — | — |
| Volatility (60d) | 96.2% | 82.2% |
| Short % of float | 21.9% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).